Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Saba NayarJoana CamposCharlotte G SmithValentina IannizzottoDavid H GardnerSerena ColafrancescoElena PipiFlorian KollertKelly J HunterCharlotte BrewerChristopher Dominic BuckleySimon J BowmanRoberta PrioriGuido ValesiniMaria JuarezWilliam A FahyBenjamin A FisherAndrew PayneRodger A AllenFrancesca BaronePublished in: Annals of the rheumatic diseases (2018)
These data demonstrate activation of PI3Kδ pathway within the glands of patients with pSS and its contribution to disease pathogenesis in a model of disease, supporting the exploration of the therapeutic potential of PI3Kδ pathway inhibition in this condition.